L-citrulline prevents alveolar and vascular derangement in a rat model of moderate hyperoxia-induced lung injury

Lung

Volumn 190, Issue 4, 2012, Pages 419-430

  Grisafi, Davide ^a   Tassone, Evelyne ^a   Dedja, Arben ^a   Oselladore, Barbara ^a   Masola, Valentina ^a   Guzzardo, Vincenza ^a   Porzionato, Andrea ^a   Salmaso, Roberto ^a   Albertin, Giovanna ^a   Artusi, Carlo ^b   Zaninotto, Martina ^b   Onisto, Maurizio ^a   Milan, Anna ^a   MacChi, Veronica ^a   De Caro, Raffaele ^a   Fassina, Ambrogio ^a   Bordigato, Michela Alfiero ^a   Chiandetti, Lino ^a   Filippone, Marco ^a   Zaramella, Patrizia ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

E NOS; Hyperoxia; L citrulline; MMP2; VEGF

Indexed keywords

ARGININE; CITRULLINE; GELATINASE A; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROGEN OXIDE; VASCULOTROPIN; VON WILLEBRAND FACTOR;

AMBIENT AIR; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL SIZE; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HYPEROXIA; LUNG ALVEOLUS; LUNG BLOOD VESSEL; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; ANIMALS, NEWBORN; ARGININE; CITRULLINE; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HYPEROXIA; LUNG; LUNG INJURY; MATRIX METALLOPROTEINASE 2; NITRIC OXIDE; PULMONARY ALVEOLI; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84864331659     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-012-9382-z     Document Type: Article

References (41)

1. Filippone M, Sartor M, Zacchello F, Baraldi E (2003) Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet 361:753-754 (Pubitemid 36293632)
2. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH (2007) Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292:L1073-L1084 (Pubitemid 47084852)
3. Balasubramaniam V, Ingram DA (2009) Endothelial progenitors in the risk of developing bronchopulmonary dysplasia: can we include endothelial progenitor cells in BPD risk assessment? Am J Respir Crit Care Med 180:488-490
4. Abman SH, Baker C, Balasubramaniam V (2008) Growth and development of the lung circulation: mechanisms and clinical implications. In: Bancalari E (ed) The newborn lung. Saunders Elsevier, Philadelphia, pp 50-72
5. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH (2000) Inhibition of angiogenesis decreases al-veolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279:L600-L607
6. Tang K, Rossiter HB, Wagner PD, Breen EC (2004) Lung-tar-geted VEGF inactivation leads to an emphysema phenotype in mice. J Appl Physiol 97:1559-1566 (Pubitemid 39299378)
7. Kallapur SG, Bachurski CJ, Le Cras TD, Joshi SN, Ikegami M, Jobe AH (2004) Vascular changes after intra-amniotic endotoxin in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol 287:L1178-L1185 (Pubitemid 39507195)
8. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH (2005) Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58:22-29 (Pubitemid 40967424)
9. Mc Curnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, Shaul PW (2005) Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288:L450-L459 (Pubitemid 40229510)
10. Ter Horst SA, Walther FJ, Poorthuis BJ, Hiemstra PS, Wagenaar GT (2007) Inhaled nitric oxide attenuates pulmonary inflamma-tion and fibrin deposition and prolongs survival in neonatal hy-peroxic lung injury. Am J Physiol Lung Cell Mol Physiol 293: L35-L44 (Pubitemid 47080713)
11. Bode-Böger SM, Muke J, Surdacki A, Brabant G, Böger RH, Frölich JC (2003) Oral 1-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med 8:77-81 (Pubitemid 37168247)
12. Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG (2001) Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24:875-880 (Pubitemid 33636062)
13. Walker HA, Mc Ging E, Fisher I, Böger RH, Bode-Böger SM, Jackson G, Ritter JM, Chowienczyk PJ (2001) Endothelium-dependent vasodilation is independent of the plasma L-arginine/ ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol 38:499-505 (Pubitemid 32721780)
14. Morris SM Jr (2004) Enzymes of arginine metabolism. J Nutr 134:2743S-2747S (Pubitemid 39315214)
15. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, Cynober L (2005) Almost all about L-citrulline in mammals. Amino Acids 29:177-205
16. Waugh WH, Daeschner CW, Files BA, Mc Connell ME, Strandjord SE (2001) Oral L-citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results. J Natl Med Assoc 93:363-371 (Pubitemid 33614747)
17. Schwedhelm E, Maas R, Freese R, Jung D, Lukacs Z, Jambrecina A, Spickler W, Schulze F, Böger RH (2008) Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol 65:51-59 (Pubitemid 350265175)
18. Solomonson LP, Flam BR, Pendleton LC, Goodwin BL, Eichler DC (2003) The caveolar nitric oxide synthase/arginine regener-ation system for NO production in endothelial cells. J Exp Biol 206:2083-2087 (Pubitemid 36761811)
19. Greenlee KJ, Werb Z, Kheradmand F (2007) Matrix metallo-proteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 87:69-98
20. Chetty C, Lakka SS, Bhoopathi P, Rao JS (2010) MMP-2 alters VEGF expression via alpha Vbeta3 integrin-mediated PI3 K/AKT signaling in A549 lung cancer cells. Int J Cancer 127:1081-1095
21. Guidolin D, Albertin G, Spinazzi R, Sorato E, Mascarin A, Cavallo D, Antonello M, Ribatti D (2008) Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2. Peptides 29:2013-2023
22. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonak J, Lind K, Sindelka R, Sjoback R, Sjogreen B, Strombom L, Stahlberg A, Zoric N (2006) The real-time polymerase chain reaction. Mol Aspects Med 27:95-125
23. Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Ros-olen A (2005) Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Int J Oncol 27:791-798
24. Thurlbeck WM (1975) Postnatal growth and development of the lung. Am Rev Respir Dis 111:803-844
25. Yi M, Jankov RP, Belcastro R, Humes D, Copland I, Shek S, Sweezey NB, Post M, Albertine KH, Auten RL, Tanswell AK (2004) Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat Am J Respir Crit Care Med 170:1188-1196 (Pubitemid 39577377)
26. Masood A, Yi M, Lau M, Belcastro R, Shek S, Pan J, Kantores C, Mc Namara PJ, Kavanagh BP, Belik J, Jankov RP, Tanswell AK (2009) Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats. Am J Physiol Lung Cell Mol Physiol 297:L920-L930
27. Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, Robinson KA, Allen MC (2011) Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 127:e414-e422
28. Vadivel A, Aschner JL, Rey-Parra GJ, Magarik J, Zeng H, Summar M, Eaton F, Thébaud B (2010) L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats. Pediatr Res 68:519-525
29. Husain AN, Siddiqui NH, Stocker JT (1998) Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29:710-717 (Pubitemid 28322056)
30. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729 (Pubitemid 32578778)
31. Duda DG, Fukumura D, Jain RK (2004) Role of e NOS in neo-vascularization: NO for endothelial progenitor cells. Trends Mol Med 10:143-145 (Pubitemid 38410970)
32. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R (1997) Nitric oxide synthase lies down-stream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625-2634 (Pubitemid 27259809)
33. Dulak J, Józkowicz A (2003) Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies. Antioxid Redox Signal 5:123-132 (Pubitemid 36337023)
34. Ananthakrishnan M, Barr FE, Summar ML, Smith HA, Kaplo-witz M, Cunningham G, Magarik J, Zhang Y, Fike CD (2009) L-citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 297:L506-L511
35. Crosby LM, Waters CM (2010) Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298:L715-L731
36. Van Hinsbergh VW, Engelse MA, Quax PH (2006) Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26:716-728 (Pubitemid 43732143)
37. Walter A, Etienne-Selloum N, Sarr M, Kane MO, Beretz A, Schini-Kerth VB (2008) Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols. J Vasc Res 45:386-394
38. Le NT, Xue M, Castelnoble LA, Jackson CJ (2007) The dual personalities of matrix metalloproteinases in inflammation. Front Biosci 12:1475-1487 (Pubitemid 46846846)
39. Kheradmand F, Rishi K, Werb Z (2002) Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. J Cell Sci 115:839-848 (Pubitemid 34196343)
40. Danan C, Jarreau PH, Franco ML, Dassieu G, Grillon C, Abd Alsamad I, Lafuma C, Harf A, Delacourt C (2002) Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 283:L1086-L1093 (Pubitemid 35204901)
41. Schulz CG, Sawicki G, Lemke RP, Roeten BM, Schulz R, Cheung PY (2004) MMP-2 and MMP-9 and their tissue inhibitors in the plasma of preterm and term neonates. Pediatr Res 55:794-801 (Pubitemid 38520446)